Immunotolerance and prevention of ocular autoimmune disease.

about

Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis.T cell mechanisms in experimental autoimmune uveoretinitis: Susceptibility is a function of the cytokine response profile

P2860

Q37051562-11688301-4AAD-4DB6-9CD6-7E55A39DA5C3 Q57281052-30C5F940-EC18-4247-96AD-84AB8D65688C

P2860

Immunotolerance and prevention of ocular autoimmune disease.

Item

http://www.wikidata.org/entity/Q40927838

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Immunotolerance and prevention of ocular autoimmune disease.

@en

type

Item

label

Immunotolerance and prevention of ocular autoimmune disease.

@en

prefLabel

Immunotolerance and prevention of ocular autoimmune disease.

@en

P1476

Immunotolerance and prevention of ocular autoimmune disease.

@en

P2093

Rizzo LV

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of anterior chamber-associated immune deviation requires an intact, functional spleen

The mechanism of action of cyclosporin A and FK506

Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity.

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

Thymic selection.

Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection.

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

Antigen-driven bystander suppression after oral administration of antigens.

Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens.

Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system.

P304

857-864

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02713689508995809

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rachel R Caspi

P577

1995-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8529426

http://www.w3.org/2001/XMLSchema#string

Immunotolerance and prevention of ocular autoimmune disease.

about

P2860

P2860

Immunotolerance and prevention of ocular autoimmune disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698